Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative HALO - Halozyme Therapeutics, Inc.
154 M
LAST VALUE
3.70%
2 YEAR CAGR
14.84%
5 YEAR CAGR
15.69%
10 YEAR CAGR